1 / 38

Pulmonary Function Testing

Pulmonary Function Testing. Let’s catch our breath Eddie Needham, MD, FAAFP Program Director Emory Family Medicine Residency Program. Learning Objectives The Astute Learner will:. Become familiar with indications for performing PFTs. Become adept at interpreting PFTs.

adria-lee
Download Presentation

Pulmonary Function Testing

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pulmonary Function Testing Let’s catch our breath Eddie Needham, MD, FAAFP Program Director Emory Family Medicine Residency Program

  2. Learning ObjectivesThe Astute Learner will: • Become familiar with indications for performing PFTs. • Become adept at interpreting PFTs. • Perform and interpret a PFT on a colleague. • Breath deep – it feels good 

  3. Lung Volumes and Capacities • There are four basic lung volumes: • Inspiratory reserve volume (IRV) • Tidal volume (TV) • Expiratory reserve volume (ERV) • Residual volume (RV) • In various combinations, these lung volumes then form lung capacities. • E.g., Vital capacity = IRV + TV + ERV

  4. Indications for Pulmonary Function Testing • Patients 45 years old and older who have ever smoked. • Patients with prolonged or excessive cough or sputum production. • Patients with a history of exposure to lung irritants. Petty TL et al, NHLBI Workshop Summary, JAMA, 1997; 277: 246-53.

  5. Indications for Pulmonary Function Testing • Detecting pulmonary disease • Pulmonary symptoms – chest pain, orthopnea, cough, phlegm production, dyspnea, wheezing • Physical findings – Chest wall problems, cyanosis, clubbing, decreased breath sounds • Abnormal labs/x-rays – ABG, Chest X-Ray Barreiro TJ and Perillo, I. An Approach to Interpreting Spirometry, AFP, March 1, 2004; 69: 1107-14.

  6. Assessing disease severity and progression Pulmonary disease – COPD, Cystic fibrosis, Interstitial lung disease, Sarcoidosis Cardiac disease – CHF, Congenital heart disease, Pulmonary hypertension Neuromuscular disease – Amyotrophic lateral sclerosis, Guillain-Barre syndrome, Multiple sclerosis, Myasthenia gravis Indications for Pulmonary Function Testing Barreiro TJ and Perillo, I. An Approach to Interpreting Spirometry, AFP, March 1, 2004; 69: 1107-14.

  7. Indications for Pulmonary Function Testing • Pre-operative risk stratification • Thoracic surgery • Cardiac surgery • Organ transplantation • General surgical procedures • Evaluating disability and impairment Barreiro TJ and Perillo, I. An Approach to Interpreting Spirometry, AFP, March 1, 2004; 69: 1107-14.

  8. Needham’s Take onIndications for Pulmonary Function Testing • Possible COPD?  Just do it • Convincing a smoker to stop?  Just do it • Prolonged cough?  Just do it • Abnormal physical exam findings?  Just do it Slide sponsored by …

  9. Actual PFT Performance Technique • Prepare the equipment – find a nurse who knows (or is that nose?) what to do.  • Patient should be seated with nose clip in place. • The patient needs to practice the exercise before actually performing the test. Have the patient breath in and out deeply several times. • Ask the patient to breath in as deeply as they can. Jackson, E. Pfenniger’s Texbook of Procedures, Chapter 62, 485-492.

  10. Actual PFT Performance Technique • The patient should place their mouth completely over the mouthpiece, not inside it. • Ask the patient to blow out as fast and as quick as they can for at least six seconds. Enthusiatically coach the patient – jump, shout, get down, hoot and holler… “Blow, blow, come on, blow more, you can do it!” Jackson, E. Pfenniger’s Texbook of Procedures, Chapter 62, 485-492.

  11. Actual PFT Performance Technique • Once the patient has blown out as much as they can, ask them to then inhale as deeply as they can. • Repeat the whole test three times. The goal is to get a reproducible result that is consistent. • You may need to repeat the test more than three times in order to obtain an internally valid test. Jackson, E. Pfenniger’s Texbook of Procedures, Chapter 62, 485-492.

  12. Normal Values • FVC is the total amount of air a person can exhale, usually measured in six seconds. • 80 – 120% of predicted is a normal value • 70 – 80% demonstrates mild reduction/restriction • 50 – 70% demonstrates moderate reduction • <50% demonstrates severe reduction • FEV1 is the amount of air a person can exhale in one second. • 80 – 120% of predicted is a normal value

  13. Normal Values • FEV1/FVC ratio is the percentage of FVC that can be expired in one second. • 75 – 80% is normal • 60 – 80% demonstrates mild obstruction • 50 – 60% demonstrates moderate obstruction • <50% demonstrates severe obstruction

  14. Normal Values • FEF25-75 reflects small airway function • >80% is normal • 60 – 80% reflects mild obstruction in the small airways • 40 – 60% reflects moderate obstruction • <40% reflects severe obstruction

  15. Perform test

  16. PFT Interpretation • Three steps in interpretation • Is the test valid? • Interpret the test • Classify severity of disease if present

  17. Validity • The test is valid is you have good patient effort and the three tests performed are internally consistent. • You may notice a learning curve in that the latter tests are better performed than the former. • Make sure that the tests are maximal effort. You need to be really aggressive in coaching your patient.

  18. PFT Interpretation • Assess FVC, FEV1, and FEV1/FVC ratio. • FVC and FEV1 normal, with a normal FEV1/FVC ratio: • Normal Test …yeah!!! • FVC decreased, FEV1 low or normal, and a normal to high FEV1/FVC ratio: • Restrictive lung disease • FVC normal or low, FEV1 low, and a low FEV1/FVC ratio: • Obstructive lung disease

  19. Actual Predicted % Predicted FVC 4.0 4.5 88 FEV1 3.4 4.2 89 FEV1/FVC 85 82 112 FEF25-75 Normal

  20. Actual Predicted % Predicted FVC 2.0 4.0 50 FEV1 1.8 3.7 47 FEV1/FVC 90 82 112 FEF25-75 Restrictive Pattern

  21. Actual Predicted % Predicted FVC 4.0 4.5 88 FEV1 2.4 4.2 58 FEV1/FVC 60 82 76 FEF25-75 2.2 4.4 50 Obstructive Pattern

  22. Special Techniques • Beta Agonist Challenge • Methacholine Challenge • DLCO

  23. Beta Agonist Challenge • Perform this when there is a suspicion that the obstructive defect may be reversible –> asthma. • Give the patient a beta agonist treatment (two puffs of an albuterol MDI or an albuterol nebulizer) and repeat the PFTs several minutes later. If you notice a 12% or more increase in FEV1, then you have diagnosed reversible airway disease/asthma.

  24. Diffuse capacity of carbon monoxide in the lung DLCO • After performing the standard PFTs, the patient then inhales trace amounts of carbon monoxide. • CO traverses the alveolar capillary beds much more readily than CO2 or O2. • As such, most of the CO inhaled should be absorbed. • When it is not, this suggests pulmonary scarring consistent with pulmonary fibrosis. Search for a cause.

  25. Methacholine Challenge • If you have a suspicion that the patient might have exercise-induced bronchospasm (EIB), then refer them to a pulmonary lab where they can do provocative testing with methacholine. • If the patient has a decrease in their FEV1/FVC ratio with the inhalation of methacholine, then you have diagnosed EIB. • Pretreat before exercise with albuterol or cromolyn.

  26. PFTs

  27. Case 1 Actual Predicted % Predicted FVC 3.8 4.5 83 FEV1 2.2 4.2 47 FEV1/FVC 59 82 72 FEF25-75 1.6 3.7 43 Survey says … COPD

  28. Case 2 Actual Predicted % Predicted FVC 2.9 4.5 64 FEV1 2.5 4.2 59 FEV1/FVC 89 82 113 FEF25-75 3.7 3.5 102

  29. Case 2 Actual Predicted % Predicted FVC 2.9 4.5 64 FEV1 2.5 4.2 59 FEV1/FVC 89 82 113 FEF25-75 3.7 3.5 102 DLCO is decreased when measured Restrictive lung pattern from Amiodarone

  30. Case 3 Actual Predicted % Predicted FVC 4.0 4.5 88 FEV1 2.6 4.2 57 FEV1/FVC 65 82 71 FEF25-75 1.7 3.6 47 Beta agonist treatment Actual Predicted % Predicted FVC 4.1 4.5 91 FEV1 3.6 4.2 89 FEV1/FVC 90 82 112 FEF25-75 3.2 3.6 91 Reversible obstructive defect, A.K.A ???

  31. Case 4 Actual Predicted % Predicted FVC 4.0 4.5 88 FEV1 3.6 4.2 89 FEV1/FVC 90 82 112 FEF25-75 3.1 3.4 95 Normal 

  32. Case 5 Actual Predicted % Predicted FVC 4.0 4.5 88 FEV1 3.3 4.2 81 FEV1/FVC 83 82 101 FEF25-75 1.7 3.5 48 Small Airways Defect

  33. Case 6 Actual Predicted % Predicted FVC 3.5 5.3 68 FEV1 3.1 4.6 68 FEV1/FVC 93 82 117 FEF25-75 3.7 3.3 120 By the way, the patient’s BMI = 47 … Restrictive pattern in obese patient

  34. Take a deep breath,we’re done.

More Related